Dawn Biopharma
Overview
Dawn Biopharma is a biopharmaceutical investment platform controlled by KKR, focusing on innovative medicines and therapies. Established to own and support a diverse portfolio of companies committed to the development of highly innovative medicines and therapies, Dawn Biopharma aims to provide flexible capital to innovators and thought leaders across the life sciences ecosystem with a shared vision of delivering life-changing medicines to patients in need. Dawn Biopharma's strategy involves investing in companies at various stages of development, from early-stage ventures to more mature businesses, across a broad spectrum of therapeutic areas. The firm seeks to partner with organizations that demonstrate strong potential for growth and innovation, particularly those developing novel treatments with significant unmet medical needs. By leveraging KKR's extensive resources and expertise, Dawn Biopharma aims to accelerate the growth and success of its portfolio companies, contributing to advancements in healthcare and patient outcomes. The firm's investment philosophy centers on collaboration and long-term value creation. Dawn Biopharma works closely with its portfolio companies, providing not only capital but also strategic guidance and operational support. This approach is designed to foster innovation, enhance operational efficiency, and drive sustainable growth, ultimately leading to the development of transformative therapies that address critical health challenges worldwide.
Investment Focus
- Companies developing innovative medicines and therapies
- Strong potential for growth and innovation
- Novel treatments with significant unmet medical needs
Portfolio Companies
Reach Dawn Biopharma directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Dawn Biopharma
What sectors does Dawn Biopharma invest in?
Dawn Biopharma invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Delaware, United States. Dawn Biopharma is listed as a private equity in the ConnectSafely investor database.
What stage does Dawn Biopharma invest at?
Dawn Biopharma backs companies at Early Stage, Growth and Late Stage, writing cheques of 5M - 50M.
Which regions does Dawn Biopharma invest in?
Dawn Biopharma invests across United States, Europe and Asia.
What companies has Dawn Biopharma invested in?
Dawn Biopharma's portfolio includes Adcytherix, Adcendo ApS and Vivoryon Therapeutics.
Last updated · Source: ConnectSafely investor database
